NUS · XBRL financial data

Nu Skin Enterprises financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (NUS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	499	489*	417	439	430	446*	364	386	364	370*	321	320
Cost of goods and services sold	207	136*	123	132	129	166*	118	120	107	108*	106	102
Gross profit	292	352*	294	307	301	279*	247	266	257	262*	214	218
Research and development	—	year only	—	—	—	year only	—	—	—	year only	—	—
General and administrative	131	145*	125	118	116	121*	113	107	105	107*	99	91
Total operating expenses	319	336*	285	433	283	332*	257	235	235	239*	210	278
Operating income (loss)	(26)	16*	9	(126)	18	(53)*	(10)	31	22	23*	4	(59)
Interest expense	8	7*	7	7	7	6*	3	3	4	4*	4	3
Income tax expense (benefit)	3	2*	2	(13)	5	(22)*	27	6	(1)	4*	1	187
Net income (loss)	(37)	7*	(1)	(118)	8	(36)*	108	21	17	14*	2	(250)
Earnings per share, basic USD per share	(0.74)	0.15*	(0.01)	(2.38)	0.17	(0.73)*	2.16	0.43	0.35	0.30*	0.04	(5.14)
Earnings per share, diluted USD per share	(0.74)	0.15*	(0.01)	(2.38)	0.17	(0.73)*	2.14	0.43	0.34	0.28*	0.04	(5.14)
Weighted average shares, basic millions of shares	50	49*	50	50	50	50*	50	49	49	49*	48	49
Weighted average shares, diluted millions of shares	50	49*	50	50	50	50*	50	49	50	51*	49	49

Fiscal quarters (NUS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	233	256	213	224	228	187	204	264	252	239	199	190
Short-term investments	17	12	9	9	10	11	10	1	1	1	2	2
Accounts receivable	77	73	67	72	69	51	57	60	49	40	45	49
Inventory	291	280	265	244	248	190	189	180	179	179	179	191
Prepaid and other current assets	83	81	94	106	99	73	66	66	68	90	99	76
Total current assets	701	702	647	654	653	539	525	572	548	548	523	508
Property and equipment, net	429	433	423	412	411	380	380	374	375	377	382	380
Right-of-use asset	86	90	93	88	86	73	79	78	80	74	70	65
Goodwill	229	231	231	100	100	84	84	84	84	84	84	5
Total assets	1,793	1,806	1,742	1,586	1,583	1,469	1,391	1,444	1,424	1,405	1,377	1,122
Accounts payable	49	44	32	36	33	35	34	29	29	26	29	38
Accrued liabilities	245	260	247	242	247	218	207	220	206	218	208	199
Current portion of long-term debt	140	25	30	30	60	30	20	35	20	20	20	20
Total current liabilities	434	329	309	309	339	297	260	284	254	264	257	256
Long-term debt	363	478	453	428	373	364	219	214	209	204	204	194
Lease liability, non-current	68	71	74	70	68	58	62	62	62	58	54	50
Total liabilities	971	984	932	900	876	817	637	656	625	600	583	579
Retained earnings	1,882	1,870	1,867	1,746	1,751	1,712	1,816	1,835	1,849	1,860	1,859	1,607
Total stockholders' equity	822	822	810	686	707	651	754	788	800	805	794	543
Total liabilities and equity	1,793	1,806	1,742	1,586	1,583	1,469	1,391	1,444	1,424	1,405	1,377	1,122
Common shares outstanding (cover page) millions of shares	49	49	50	50	50	50	49	49	49	48	49	49

Fiscal quarters (NUS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(37)	7*	(1)	(118)	8	(36)*	108	21	17	14*	2	(250)
Stock-based compensation	4*	3*	4	4*	3*	3*	9	6*	6*	3*	4	1*
Depreciation and amortization	18	19*	18	18	17	16*	14	13	12	13*	12	13
Net cash from operating activities	51*	54*	3	51*	31*	26*	0	36*	27*	17*	(4)	11*
Purchases of property and equipment	12*	20*	12	8*	9*	13*	14	0*	10*	11*	14	6*
Net cash from investing activities	(12)*	(15)*	(9)	(9)*	(7)*	(14)*	182	9*	(10)*	(10)*	(14)	(6)*
Share repurchases	13*	0*	0	0*	0*	0*	5	0*	5*	10*	5	0*
Dividends paid	19*	19*	3	3*	3*	3*	3	3*	3*	3*	3	3*
Proceeds from long-term debt	0*	0*	0	0*	15*	0*	0	15*	40*	0*	225	0*
Repayments of long-term debt	5*	0*	20	25*	40*	40*	155	5*	60*	5*	225	10*
Net cash from financing activities	(38)*	(20)*	(32)	(29)*	(29)*	(44)*	(166)	9*	(27)*	(19)*	(20)	(13)*
Net change in cash	(2)*	23*	(44)	12*	4*	(41)*	17	60*	(12)*	(13)*	(40)	(9)*

SIC 5122 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (5122) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Nu Skin Enterprises	190	320	11*	48.7M	—	Q2 FY26 10-QJun 30, 2026
Herbalife	409	1,350	151*	104.9M	—	Q3 FY26 10-QSep 30, 2026
DataMeds AIadded: same SIC	2.5	1.8	(2.9)*	3.1M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
Cosmos Healthadded: same SIC	1.8	19	(1.7)*	100.6M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
Stemtechadded: same SIC	0.2	0.6	(0.1)*	3.0B	4.5 quarters	Q2 FY26 10-QJun 30, 2026
Cencoraadded: same SIC	2,815	84,755	2,654*	190.8M	—	Q3 FY26 10-QJun 30, 2026
Sharing Services Globaladded: same SIC	0.7	2.1	(0.4)*	309,652	1.7 quarters	Q2 FY25 10-QSep 30, 2024
Cardinal Healthadded: same SIC	4,856	year only	year only	232.6M	—	Q4 FY26 10-KJun 30, 2026
HWH Internationaladded: same SIC	1.5	0.1	0.5*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.